Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate CancerSusan Halabi, Nicholas J. Vogelzang, Ellen B. Kaplan et al.|Journal of Clinical Oncology|2003Cited by 678
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103Chaitra S. Ujjani, Bruce D. Cheson, Sin‐Ho Jung et al.|Blood|2016Cited by 59